Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems

The SARS-CoV-2 virus has caused a global crisis, resulting in 0.5 billion infections and over 6 million deaths as of March 2022. Fortunately, infection and hospitalization rates were curbed due to the rollout of DNA and mRNA vaccines. However, the efficacy of these vaccines significantly drops a few...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalash, Ahmed O., Azuar, Armira, Madge, Harrison Y. R., Modhiran, Naphak, Amarilla, Alberto A., Liang, Benjamin, Khromykh, Alexander A., Hussein, Waleed M., Chappell, Keith J., Watterson, Daniel, Young, Paul R., Skwarczynski, Mariusz, Toth, Istvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024957/
https://www.ncbi.nlm.nih.gov/pubmed/35456690
http://dx.doi.org/10.3390/pharmaceutics14040856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024957/
https://www.ncbi.nlm.nih.gov/pubmed/35456690
http://dx.doi.org/10.3390/pharmaceutics14040856

Ejemplares similares